Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 27
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05308966 | Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) | ||
| NCT01956331 | Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer | ||
| NCT02785562 | Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression. | ||
| NCT05049044 | Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE) | ||
| NCT00433563 | Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer | ||
| NCT06247826 | Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion | ||
| NCT00199758 | Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer | ||
| NCT06620835 | Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib | ||
| NCT06393816 | FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum | ||
| NCT06552234 | Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC | ||
| NCT03801304 | Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer | ||
| NCT00418704 | Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) | ||
| NCT04547504 | PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 % | ||
| NCT01631136 | Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer | ||
| NCT00037713 | Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG | ||
| NCT05122806 | Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC | ||
| NCT00419042 | Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) | ||
| NCT00418743 | Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC) | ||
| NCT02162537 | Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases | ||
| NCT00651456 | Mesothelioma Avastin Plus Pemetrexed-cisplatin Study | ||
| NCT02086071 | Feasibility of re Biopsies at Progression | ||
| NCT00284778 | Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer | ||
| NCT06646471 | PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies | ||
| NCT02178397 | A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR | ||
| NCT05285033 | RW Effectiveness of Lurbinectedin in Extensive Stage SCLC | ||
| NCT03305133 | Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC) | ||
| NCT02293733 | Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) |
